Search for: "C. Ester" Results 21 - 40 of 85
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2019, 7:28 am by Jessica Kroeze
C J J C van Nispen, dated 19 December 2018.D33: The Paris Convention Centenary, wipo-pub-875, ISBN 92-805-0099-6, WIPO 1983, pages 5, 15, 16, 27 to 31.D34: Bodenhausen, Guide to the application of the Paris Convention for the protection of industrial property, BIRPI 1968, pages 35 to 38.It further requested that two questions be referred to the Enlarged Board of Appeal (see below) or, alternatively, that a correction be allowed under Rule 139 EPC (see below). [read post]
22 Mar 2019, 4:48 am by Brian Cordery
; or c) can an SPC only be granted for a new therapeutic application where the earlier MAs were for veterinary medicinal products? [read post]
21 Mar 2019, 10:16 am
  The product cannot already be the subejct of an SPC (Article 3(c)) and the MA referred to at Article 32(b) has to be the first authorization to place the product on the market as a medicinal product. [read post]
2 Dec 2018, 4:00 am by Administrator
Tout comme dans Chiasson c. [read post]
17 Sep 2018, 9:14 am by Dennis Crouch
  at a temperature between 140° C. and 200° C. [read post]
6 Sep 2018, 2:08 pm by Rebecca Tushnet
Ester C Company, --- F.Supp.3d ----, 2018 WL 4210139, No. 12-CV-0041 (E.D.N.Y. [read post]
31 Jan 2018, 10:05 pm
(c) Is the position unclear necessitating a reference to the CJEU? [read post]
28 Oct 2017, 3:22 am by Dennis Crouch
In her decision, Judge Huff granted Plaintiffs Rule 12(c) motions for judgment on the pleadings – ruling that all claims of the five asserted patents were invalid for claiming ineligible subject matter under 35 U.S.C. [read post]
9 May 2017, 4:42 am
  Subsequently, the CJEU held in Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [EU: C:2013:835] that Article 3(a) must be interpreted as meaning that it was not necessary for the active ingredient to be identified in the claim by means of a structural formula. [read post]
14 Feb 2016, 4:00 am by Administrator
Intitulé : Agence du revenu du Québec c. [read post]
19 Jun 2015, 12:00 am by Giorgio Buono
After having outlined the path that led to the adoption of the Directive and showed the need to modernise Union law in this area, this article analyses a) the European Professional Card; b) partial access; c) professional traineeship; d) common training principles; and e) the further most important revisions of Directive 2005/36/EC aiming at promoting the free movement of professionals. [read post]
7 Jan 2015, 6:39 am by Gene Quinn
Patent No. 8865685, which is titled Esters for Treatment of Ocular Inflammatory Conditions. [read post]
23 May 2014, 6:08 pm
Controlled-release oral pharmaceutical compositions containing as an active ingredient 5-amino-salicylic acid, comprising:a) an inner lipophilic matrix consisting of substances selected from the group consisting of unsaturated and/or hydrogenated fatty acid, salts, esters or amides thereof, fatty acid mono-, di- or triglycerid[e]s, waxes, ceramides, and cholesterol derivatives with melting points below 90° C., and wherein the active ingredient is dispersed both in said the… [read post]
26 Apr 2013, 9:03 am by Rebecca Tushnet
Buy This All-Natural Product and Become Stronger, Healthier, and Sexier: The Latest in False Advertising Consumer Class Actions Moderator: Patricia E. [read post]